BIO.AX ASX
Biome Australia Limited
1W: +3.7%
1M: +18.3%
3M: +58.5%
YTD: -3.5%
1Y: -18.4%
3Y: +236.0%
A$0.40 ($0.28)
-0.02 (-4.76%)
Weekly Expected Move ±8.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#3
of 3
Medical - Pharmaceuticals
Technical Signal Map
1 Bullish
0 Neutral
2 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| BIO.AX Biome Australia Limited | $100M | 25.5 | 62.2 | 221.3 | 21.2 | 108.9 | 5 | BULLISH | -18.4 |
| MYX.AX Mayne Pharma Group Limited | $230M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 4 | BEARISH | -45.1 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $290M | — | — | — | — | — | — | BEARISH | — |
| BIO.AX Biome Australia Limited | $100M | 25.5 | 62.2 | 221.3 | 21.2 | 108.9 | 5 | BULLISH | -18.4 |
| MYX.AX Mayne Pharma Group Limited | $230M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 4 | BEARISH | -45.1 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $290M | — | — | — | — | — | — | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
BIO.AX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F